Holen Sie sich die Stockscreener-App
8.63
1.54%
-0.16
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
Liquidity Mapping Around (CRMD) Price Events - Stock Traders Daily
CRMD,PEP Revenue Breakdown - Finviz
CORMEDIX INC. Files 8-K: Company Details, Stock Info & SEC Filing Summary for June 25, 2026 - Minichart
CorMedix (NASDAQ: CRMD) replaces CBIZ with Ernst & Young as auditor - Stock Titan
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Yahoo Finance
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - TradingView
CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path - TradingView
CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
CorMedix Inc. (CRMD) Slips 2.74% as Stock Tests Support Near $7.25Volatility Smirk - dars.gov.et
CorMedix Inc.(NasdaqGM: CRMD) added to Russell 2000 Value Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Microcap Value Benchmark Index - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
Enterprise value to EBIT forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
Price to book forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Price to sales forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Is Now The Time To Put CorMedix (NASDAQ:CRMD) On Your Watchlist? - Moomoo
Price to earnings forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Form DEF 14A CorMedix Inc For: 25 June - Investing.com UK
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
Form DEF 14A CorMedix Inc For: 25 June By Investing.com - Investing.com Australia
CorMedix Inc. Actuals & Estimates (NASDAQ:CRMD) - TradingView
CRMD Forecast — Price Target — Prediction for 2027 - TradingView
CorMedix (CRMD) shareholders affirm directors but vote down multiple charter amendments - Stock Titan
CorMedix Inc (CRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why (CRMD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Raised 2026 Guidance and DefenCath Momentum Might Change The Case For Investing In CorMedix (CRMD) - simplywall.st
CorMedix Inc (CRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CorMedix Inc. (CRMD) Achieves Remarkable 384.60% Revenue Growth - GuruFocus
CorMedix Inc (CRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CorMedix Inc (CRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CorMedix Inc (CRMD) Institutional Confidence - TradingKey
CorMedix Inc (CRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CorMedix Inc (CRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CorMedix Inc (CRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CorMedix Inc (CRMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
CorMedix (CRMD) Stock Could Be 27.8% Undervalued After Q1 Results And Raised Outlook - Yahoo Finance
The Bull Case For CorMedix (CRMD) Could Change Following Raised 2026 Guidance And DefenCath MomentumLearn Why - Yahoo Finance
CorMedix Inc. (CRMD) Reports Q1 2026 Results - Insider Monkey
CorMedix (CRMD) holder reports 4.62M shares, 5.89% stake - Stock Titan
CorMedix (CRMD): Investor reports 4.62M shares, 5.89% stake - Stock Titan
5 Most Profitable Small Cap Stocks to Buy - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
CRMD Q1 2026 Earnings: EPS Beat of 31.72% Drives Stock HigherProfit Recovery Report - newsline.com
Federal appeals court upholds CorMedix patent win over Nexus - Investing.com UK
Federal Circuit Affirms CorMedix Patent Victory, Blocking Nexus Generic MINOCIN® Launch Until Patent Expiration 1 - minichart.com.sg
Federal appeals court upholds CorMedix patent win over Nexus By Investing.com - Investing.com South Africa
Appeals court upholds CorMedix (NASDAQ: CRMD) MINOCIN® patents and injunction - Stock Titan
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation - GlobeNewswire
Can CorMedix Turn Launch Execution Into Momentum? - Kalkine Media
1.95%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):